The pharmacokinetics of pranlukast in healthy young and elderly subjects
Pranlukast is a novel LTD4 antagonist under development for the treatment of asthma. To assess the effect of age, the pharmacokinetics of pranlukast were studied in healthy young (9 females, 10 males, mean 30 years) and elderly subjects (9 per sex, mean 70.4 years). After an overnight fast volunteer...
Saved in:
Published in | International journal of clinical pharmacology and therapeutics Vol. 34; no. 9; p. 375 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
01.09.1996
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!